Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07270380 · ClinicalTrials.gov registry record · NA

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

A NA study, sponsored by Biocomposites.

Recruiting
Registry status
NA
Development phase
139
Enrollment target

NCT07270380: Recruiting NA study, sponsored by Biocomposites.

NCT07270380 is a NA study that is actively recruiting participants, run by Biocomposites. The registered enrollment target is 139 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07270380, a NA study, is actively recruiting participants, sponsored by Biocomposites.

RECRUITING
Registry status
NA
Development phase
139 participants
Enrollment target

Study Summary

The purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.

Primary Outcome

Further requirement for antibiotic treatment due to persisting symptoms of infection at the site of treatment will be assessed at Month 12.

Interventions

  • DEVICE genex with gentamicin (genex G)

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2026-06
Est. Completion 2028-10
Phase NA
Biocomposites

3 total trials

What NCT07270380 shows while recruiting

NCT07270380 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which genex with gentamicin (genex G) is the first listed.

NCT07270380 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07270380 about?

NCT07270380 is a clinical study titled "Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.". The purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.

What is the current status of trial NCT07270380?

This trial is currently recruiting. It is a NA study. The enrollment target is 139 participants. The study started on 2026-06. Estimated completion is 2028-10.

What interventions are being tested in trial NCT07270380?

The interventions under investigation include: genex with gentamicin (genex G) (DEVICE).

Who is sponsoring clinical trial NCT07270380?

This trial is sponsored by Biocomposites, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07270380's enrollment target sits among peer trials

139 720th of 2000 higher than 1,281 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05645380 · 139 participants · Phase 2

    Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

  • NCT06239272 · 139 participants · Phase 1

    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • NCT06252220 · 139 participants · Phase 1

    First in Human Study in Subjects With Obesity, But Otherwise Healthy

  • NCT06537128 · 139 participants · NA

    Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07270380, the US trial registry maintained by the National Library of Medicine. NCT07270380 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.